Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study

Overview of attention for article published in Targeted Oncology, November 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#5 of 555)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 4 news outlets

twitter: 2 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 23 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 4 news stories from 4 outlets.

New potential combination therapy for sarcomas. ecancer

ecancer, 17 Jan 2018

Researchers of the Sarcoma group of the Oncobell programme at Bellvitge Biomedical Research Institute (IDIBELL) have…

Researchers successfully test a new combination therapy in sarcomas

MedicalXpress, 17 Jan 2018

Researchers of the Sarcoma group at Bellvitge Biomedical Research Institute have successfully tested a new combined therapy for…

IDIBELL researchers successfully test a new combination therapy in sarcomas

EurekAlert!, 16 Jan 2018

Researchers of the Sarcoma group of the Oncobell program - Bellvitge Biomedical Research Institute (IDIBELL) have successfully…

Investigadores del IDIBELL prueban con éxito una nueva terapia combinada en sarcomas

Jano, 11 Jan 2018

PUBLICADO EN 'TARGETED ONCOLOGY' JANO.es · 11 enero 2018 11:53 El tratamiento puesto a prueba combina la gemcitabina, una…